News
MD hails record-breaking Q1 for AI platform in ‘bearish’ market
Artificial intelligence security company Spectur has delivered a record Q1 in FY23, with $1.657 million of revenue in sales of its solar-powered surveillance platform – a solution that MD Gerard Dyson describes as being like “the first smartphone in a world of flip-phones”.
Positive signs within a sector that is ‘critical’ to Australia’s future
The Federal Government has outlined a commitment to achieve 1.2 million tech jobs in Australia by 2030, and newly released data from the Australian Bureau of Statistics indicates we are headed in the right direction.
Deja view: Fundies utter the same 9-word verdict for investors
Investors have been making the same mistake over the past six months, says Lowell Resources Fund’s John Forwood, whose comments echo those made recently by Merchant’s Andrew Chapman.
Continued double-digit revenue growth in reach for this data biz: fundie
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In May, Altor Capital’s Benjamin Harrison selected Pureprofile as one of his favourite stocks, noting its potential to grow its EBITDA margin…
Note from the MD: Markets nimble amid volatile reactions to new data
Aussie equity markets have tempered themselves this week after the S&P 500 retreated -5.33% over the past five trading days, with the XJO shedding a modest -0.81% during the same period. The VIX stacked on over 13% as everyone braces for further volatility.
Cannabis deal closes, opening door for WNX to enter market
One of Australia’s leading cannabis manufacturing facilities has been formally acquired by a joint venture partner of Wellnex Life, propelling the health and wellness innovator forward in its goal to be a first mover in the emerging over-the-counter medicinal cannabis space.
Business turnover rises as Australia weathers the global storm
Positive signs continue to emerge for Australia’s resilient business sector, with newly released figures showing turnover rose in 12 of 13 selected industries in August and all industries recorded year-on-year increases.
Well, that’s awkward – someone’s got their valuation very wrong
Investors are well versed in determining the true value of companies and deals, but it seems the art world is a different beast – with what must surely be the biggest-ever valuation disparity between an expert and collectors occurring this month.
Very well positioned to benefit from structural change, says fundie
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In May, Katana Asset Management’s Romano Sala Tenna selected Santos as one of his favourite stocks, noting its potential to generate strong…
Note from the MD: Markets surge in biggest single-day rally since mid 2020
Aussie equity markets surged yesterday on the back of a smaller-than-expected interest rate hike by the RBA. Coming in at 25 basis points and lifting the official cash rate target to 2.6%, it was half the 50 basis point hike that was widely forecast by economists and already priced in by markets.
Why this ‘pretty bad’ market could be the greatest time to invest
It’s the parody of running funds, says Merchant’s Andrew Chapman: “Everyone wants to invest when things are going well, but that’s when it’s harder to make money. No one wants to invest when things are going bad. And ironically, that’s the best time to make money
Pain relief without prescription – Australia’s medicinal cannabis opportunity
Australia’s pharma landscape is in for arguably one of the largest developments in recent times – the long-awaited move to allow over-the-counter medicinal cannabis sales.
Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency
Receive the latest news and media directly to your inbox
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.